City Therapeutics

Cambridge, United States

City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.

$135.0M raised

Oct 2024

Series A

Biopharma Life Science Therapeutics

Top Investors

ARCH Venture PartnersFidelityInvusRock Springs CapitalRegeneron Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about City Therapeutics

How much funding has City Therapeutics raised?

City Therapeutics has raised $135.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.

Who are City Therapeutics's investors?

City Therapeutics's investors include ARCH Venture Partners, Fidelity, Invus, Rock Springs Capital, Regeneron Ventures.

Where is City Therapeutics headquartered?

City Therapeutics is headquartered in Cambridge, United States.

What does City Therapeutics do?

City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.

What stage is City Therapeutics at?

City Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 8, 2024.

MLA

"City Therapeutics — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/city-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2024). City Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/city-therapeutics

Wikipedia (cite web)

{{cite web |title=City Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/city-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 8, 2024.

Similar Companies in Biopharma